Dalbavancin Efficacy and Impact on Hospital Length-of-Stay and Treatment Costs in Different Gram-Positive Bacterial Infections.

Maria Cristina PolisenoDavide Fiore BavaroGaetano BrindicciGiovanni LuzziDomenico Maria CarrettaAntonio SpinarelliRaffaella MessinaMaria Paola MiollaTeresa Immacolata AchilleMaria Rosaria DibartolomeoMaria Dell'AeraAnnalisa SaracinoGioacchino AngaranoStefano FavaleCarlo D'AgostinoBiagio MorettiFrancesco SignorelliCamilla TagliettiSergio Carbonara

Published in: Clinical drug investigation (2021)

In this experience, the use of dalbavancin contributed to shorten LOS and treatment-related costs, especially in difficult Gram-positive infections requiring prolonged therapy.

Keyphrases

healthcare
gram negative
emergency department
multidrug resistant
mesenchymal stem cells
adverse drug
cell therapy
smoking cessation
drug induced